Skip to main content
SpringerLink
Log in

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Russell MD, et al. Modern surgery for advanced thyroid cancer: a tailored approach. Gland Surg. 2020. https://doi.org/10.21037/gs.2019.12.16.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Wirth LJ, et al. Efficacy of selpercatinib in RET-altered thyroid cancers. N Eng J Med. 2020;383(9):825–35. https://doi.org/10.1056/nejmoa2005651.

    Article  CAS  Google Scholar 

  3. Subbiah V, et al. Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (arrow): a multi-cohort, open-label, registrational, phase 1/2 study. Lancet Diabetes Endocrinol. 2021;9(8):491–501. https://doi.org/10.1016/s2213-8587(21)00120-0.

    Article  CAS  PubMed  Google Scholar 

  4. Jozaghi Y, et al. Neoadjuvant selpercatinib for advanced medullary thyroid cancer. Head Neck. 2020. https://doi.org/10.1002/hed.26527.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Contrera, et al. Neoadjuvant selective RET inhibitor for medullary thyroid cancer: a case series. In press. Thyroid.

Download references

Author information

Authors and Affiliations

  1. Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    Amber Leila Sarvestani MD, Jacob Lambdin MD & Jonathan M. Hernandez MD

  2. Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Mimi Hu MD, Maria Cabanillas MD & Steven G. Waguespack MD

  3. Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Mark E. Zafereo MD

Authors
  1. Amber Leila Sarvestani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacob Lambdin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mimi Hu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Cabanillas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Steven G. Waguespack MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jonathan M. Hernandez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mark E. Zafereo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jonathan M. Hernandez MD or Mark E. Zafereo MD.

Ethics declarations

Disclosures

M.Z. has received clinical trial research funding from Eli Lilly and Merck. S.W. is consultant/speaker for Bayer. M.C. has received research grant funding from Genentech and Merck and consulting fees from Exelixis and Bayer. M.H. has received research support from Eli Lilly.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 113 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sarvestani, A.L., Lambdin, J., Hu, M. et al. Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers. Ann Surg Oncol 31, 2202–2203 (2024). https://doi.org/10.1245/s10434-023-14854-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14854-w

Search

Navigation